Dublin, Nov. 8, 2013 (GLOBE NEWSWIRE) -- Digital Pathology Market - Slide Scanners, Analytics, Delivery Modes and Whole Slide Image Storage - Global Trends & Forecast till 2017
Research and Markets
(http://www.researchandmarkets.com/research/39sjkg/digital_pathology)
has announced the addition of the
"Digital Pathology Market - Slide Scanners (Whole Slide Imaging),
Analytics (Image Analysis Software), Delivery Modes (Web Based/
Cloud Based) and Whole Slide Image Storage - Global Trends &
Forecast till 2017" report to their offering.
The life science industry is now witnessing the second decade of
Biologic Revolution. The adoption and up gradation of technology is
increasing rapidly. Conventional practices are being replaced by
advanced technologies. The perception of pathological laboratories
needs to be improved as the consumer expectations and government
regulations towards improved patient safety, accurate diagnosis,
Electronic Medical Records (EMR) as well as personalized medicines
are growing. Pathology plays a significant role in patient care.
Digital pathology serves this purpose by providing a facility for
digital transformation of pathology and laboratory medicine.
Digital pathology is currently gaining momentum as pathologists
are seeking to achieve workflow efficiency and cost cutting in the
pathological process. It provides ready access to premium quality
slide images, enabling better and fast diagnosis, as well as
preservation of these digital slides for future reference. The
digital pathology market is driven by the factors such as reduction
in laboratory expenses, improvement in operational efficiency, and
treatment decisions and patient care. The rising prevalence of
cancer, increasing trends in drug development, companion
diagnostics, and ease of consultation are the major drivers that
are slated to propel this market. However, a few pivotal factors
restraining the growth of this market are FDA regulations in some
regions, high cost of Digital Pathology Systems (DPS),
technological problems, and conservative outlook of pathologists.
There are a few well-established firms and several small ones
operating in this industry. The major players in the market are
Aperio Technologies, Inc. (U.S.), Ventana Medical Systems (U.S.),
Leica Microsystems GmbH (Germany), Digipath (U.S.), and Hamamatsu
Photonics (Japan).
The global digital pathology market is broadly segmented into two
categories based on its products and application. The product
category includes scanners, analytics (visualization software,
information management systems and image analysis platforms),
storage and communication (sharing services, software), while the
application category comprises human pathology and animal
pathology. Both these markets are dominated by North America in
2012, followed by Europe, Asia, and Rest of the World (RoW). The
global digital pathology market is estimated to be $191.00 million
in 2012, and is poised to grow at a CAGR of 12% to reach $336.61
million by 2017.
Key Topics Covered:
1 Introduction
2 Executive Summary
3 Market Overview
4 Digital Pathology: Rationale For Adoption
5 Global Digital Pathology Market, By Products
6 Global Digital Pathology Market, By Application
7 Geographic Analysis
8 Competitive Landscape
9 Company Profiles
Companies Mentioned
- 3Dhistech, Ltd
- Aperio Technologies, Inc.
- Apollo Pacs, Inc.
- Aurora Interactive, Ltd.
- Corista, Llc
- Definiens Ag
- Digipath, Inc.
- Hamamatsu Photonics K.K.
- Huron Technologies International, Inc.
- Indica Labs, Inc.
- Leica Microsystems Gmbh
- Ligolab, Llc
- Mikroscan Technologies, Inc.
- Nikon Instruments, Inc.
- Omnyx, Llc
- Pathcentral, Inc.
- Pathxl
- Pixcelldata, Ltd.
- Sunquest Information Systems
- Ventana Medical Systems, Inc.
- Visiopharm
For more information visit http://www.researchandmarkets.com/research/39sjkg/digital_pathology
Research and Markets
Laura Wood, Senior Manager.
press@researchandmarkets.com
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector:
Medical Devices